Keith A Josephs Selected Research

Gliosis

12/2008	Apraxia of speech and nonfluent aphasia: a new clinical marker for corticobasal degeneration and progressive supranuclear palsy.
4/2005	Extending the clinicopathological spectrum of neurofilament inclusion disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Keith A Josephs Research Topics

Disease

55	Alzheimer Disease (Alzheimer's Disease) 04/2024 - 04/2007
48	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 03/2024 - 01/2004
41	Atrophy 05/2024 - 04/2005
40	Frontotemporal Dementia (Semantic Dementia) 03/2024 - 10/2003
29	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 04/2024 - 10/2002
28	Dementia (Dementias) 08/2022 - 09/2003
23	Parkinsonian Disorders (Parkinsonism) 04/2024 - 08/2002
21	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2024 - 10/2004
19	Tauopathies 05/2024 - 10/2004
13	Corticobasal Degeneration 06/2022 - 10/2003
11	Apraxias (Dyspraxia) 04/2024 - 12/2008
11	Aphasia (Dysphasia) 01/2024 - 12/2013
11	Cognitive Dysfunction 02/2022 - 06/2004
10	Motor Neuron Disease (Primary Lateral Sclerosis) 11/2022 - 07/2005
9	Primary Progressive Aphasia 12/2019 - 05/2010
8	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 11/2022 - 11/2009
7	Hippocampal Sclerosis 01/2023 - 01/2004
7	Parkinson Disease (Parkinson's Disease) 12/2019 - 09/2005
7	Tremor (Tremors) 04/2013 - 09/2003
6	Neoplasms (Cancer) 01/2023 - 06/2004
5	Amyloid Plaque 07/2023 - 01/2003
4	Proteostasis Deficiencies 04/2024 - 12/2013
4	Memory Disorders (Memory Loss) 12/2023 - 01/2014
4	Psychotic Disorders (Schizoaffective Disorder) 01/2022 - 09/2003
4	Pick Disease of the Brain (Pick's Disease) 11/2020 - 09/2005
4	Sarcoma (Soft Tissue Sarcoma) 01/2020 - 07/2010
4	Synucleinopathies 12/2019 - 10/2004
4	Multiple System Atrophy 09/2008 - 04/2005
3	Lewy Body Disease (Lewy Body Dementia) 01/2021 - 09/2008
3	Brain Diseases (Brain Disorder) 02/2012 - 06/2004
2	Hallucinations (Hallucination) 02/2022 - 01/2018
2	Vascular Diseases (Vascular Disease) 01/2022 - 06/2004
2	Language Disorders (Language Disorder) 11/2014 - 03/2014
2	Dystonia (Limb Dystonia) 01/2013 - 10/2009
2	Myoclonus (Nocturnal Myoclonus) 09/2011 - 09/2007
2	Disease Progression 10/2010 - 07/2008
2	Gliosis 12/2008 - 04/2005
2	Cerebellar Ataxia (Dysmetria) 09/2008 - 12/2004
1	Neuronal intranuclear inclusion disease 01/2024
1	Prosopagnosia 01/2024
1	Demyelinating Diseases (Demyelinating Disease) 01/2023
1	limbic-predominant age-related TDP-43 encephalopathy 01/2023
1	Fasciculation (Fasciculations) 11/2022
1	REM Sleep Behavior Disorder 02/2022
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022
1	Paraparesis 01/2021
1	Anomia (Dysnomia) 01/2021
1	Orthostatic Hypotension (Postural Hypotension) 10/2019

Drug/Important Bio-Agent (IBA)

44	DNA-Binding Proteins (DNA Binding Protein)IBA 05/2024 - 08/2008
31	Amyloid (Amyloid Fibrils)IBA 03/2024 - 03/2011
30	Proteins (Proteins, Gene)FDA Link 03/2024 - 01/2004
27	Biomarkers (Surrogate Marker)IBA 03/2024 - 07/2008
23	7- (6- fluoropyridin- 3- yl)- 5H- pyrido(4,3- b)indoleIBA 01/2024 - 01/2016
18	UbiquitinIBA 08/2022 - 01/2004
15	Apolipoproteins E (ApoE)IBA 01/2023 - 01/2003
15	ProgranulinsIBA 01/2018 - 11/2006
13	Levodopa (L Dopa)FDA LinkGeneric 02/2022 - 10/2002
11	Amyloid beta-PeptidesIBA 05/2023 - 02/2008
11	ApolipoproteinsIBA 01/2023 - 09/2003
8	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 12/2023 - 12/2008
8	SynucleinsIBA 01/2023 - 02/2007
7	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2024 - 01/2010
7	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 01/2020 - 12/2013
6	tau Proteins (tau Protein)IBA 01/2023 - 01/2004
6	alpha-SynucleinIBA 01/2017 - 08/2002
5	DNA (Deoxyribonucleic Acid)IBA 09/2013 - 01/2003
4	Protein Isoforms (Isoforms)IBA 04/2023 - 10/2007
4	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2017
4	Dopamine Agonists (Dopamine Agonist)IBA 12/2010 - 09/2005
3	IronIBA 01/2023 - 01/2022
3	N 30IBA 01/2021 - 01/2009
3	LigandsIBA 01/2019 - 01/2017
3	SteroidsIBA 05/2016 - 06/2004
3	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 06/2011 - 09/2007
2	Prostaglandins FIBA 04/2024 - 01/2020
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 03/2011
2	DipeptidesIBA 10/2019 - 01/2017
2	Complement System Proteins (Complement)IBA 01/2019 - 07/2010
2	Dopamine (Intropin)FDA LinkGeneric 07/2017 - 04/2013
2	Amino Acids FDA Link 08/2015 - 11/2011
2	Messenger RNA (mRNA)IBA 09/2013 - 10/2011
2	MicroRNAs (MicroRNA)IBA 10/2011 - 12/2008
2	AutoantibodiesIBA 06/2011 - 10/2010
2	Cholinergic ReceptorsIBA 10/2010 - 09/2007
1	Glial Fibrillary Acidic ProteinIBA 03/2024
1	thioflavin TIBA 07/2023
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2023
1	Antipsychotic Agents (Antipsychotics)IBA 01/2022
1	Indicators and Reagents (Reagents)IBA 01/2022
1	Carrier Proteins (Binding Protein)IBA 01/2022
1	Adenosine Monophosphate (AMP)IBA 01/2021
1	2- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA 09/2020
1	Dopamine Receptors (Dopamine Receptor)IBA 09/2020
1	ioflupaneIBA 09/2020
1	aspartyl- arginyl- valyl- tyrosyl- isoleucyl- histidyl- prolyl- phenylalanyl- histidyl- leucyl- valyl- isoleucyl- histidine (hTDP)IBA 05/2020
1	hydroxide ionIBA 10/2019

Therapy/Procedure

10	Therapeutics 04/2023 - 09/2005
2	Immunotherapy 06/2011 - 10/2010
1	Denervation 11/2022
1	Precision Medicine 12/2019